ms. degette and i both. >> at the gentleman revealed. just because i agreed to the format doesn't mean i agree to the witnesses being badgered by sound bite questions. >> i am just saying the format we did i just point that out. let me move to close here. mr. harrison, let's see. mr. harrison will you invoke your fifth amendment rights in response to all questions here today? bes. >> then you are excused from the witness table at this time but i advise you that you remain subject to the process of the committee and if the committee needs are such then we may recall you. you may leave. mr. stover, let me be clear mr. stover are you refusing to answer questions on the basis of the protection afforded to you under the fifth amendment of the constitution? yes or no? can the press step down a little bit so we can see each other? do you want me to repeat the question for you? that may be clear, you refusing to answer the question on the basis of the protections afforded to under the fifth amendment to the united states constitution? bes. >> mr

ms. degette's bill on notification, i mean, she put a lot of work into this. you know, we have to do everything we can to be a partner in this to find a slews. i look forward to working with both of you to the extent this committee lets me play a role. >> the chair recognizes the gentle lady from colorado. >> thank you. mr. chairman, thanks for letting me participate. it's good to be back in my old stomping grounds of the house committee, and as i know you've been discussing, congressman roonny and i introduced in a bipartisan way that preserving access to life saving medications act creating an early warning system between fda drug companies and providers so that we can respond to these drug shortages quickly and efficiently. do i think the bill will solve the root problems of the drug shortage crisis? no. do i think it's a necessary first step? absolutely. i appreciate the witnesses coming here to talk to the members of this committee. this bill came up because mr. rooney and i independently were going around, meeting with our hospitals and doctors, and sudd

ms. degette. the chair: the gentlelady is recognized for five minutes. ms. degette: mr. chairman, for too long, too many people in this body have proposed that we must make what amounts to a devil's bargain, choosing between environmental protections and jobs. today, the ideology behind that false choice brings us to the gut of gutting one of our fundamental laws, the clean air act. it has safeguarded our economy and our families' health for decades and despite heated rhetoric from the other side, it does not stand in the way of creating jobs. in 2010 alone, the clean air act prevented 160,000 premature deaths, three million lost school days and 13 million lost work days. by 2020, the clean air act, total benefit to the economy, will reach $2 trillion, outweighing the cost of 30 to 1. despite the actual numbers, today we find ourselves debating a full attack on clean air through the train act, which would represent an unprecedented up-al of our long pollution-held standards. we had a hearing in my subcommittee today talking about the alleged job loss that the majority cl

ms. degette's bill on notification, i mean, she put a lot of work into this.ou know, we have to do everything we can to be a partner in this to find a slews. i look forward to working with both of you to the extent this committee lets me play a role. >> the chair recognizes the gentle lady from colorado. >> thank you. mr. chairman, thanks for letting me participate. it's good to be back in my old stomping grounds of the house committee, and as i know you've been discussing, congressman roonny and i introduced in a bipartisan way that preserving access to life saving medications act creating an early warning system between fda drug companies and providers so that we can respond to these drug shortages quickly and efficiently. do i think the bill will solve the root problems of the drug shortage crisis? no. do i think it's a necessary first step? absolutely. i appreciate the witnesses coming here to talk to the members of this committee. this bill came up because mr. rooney and i independently were going around, meeting with our hospitals and doctors, and sudden

ms. degette. >> thank you. i would like to ask unanimous consent to put the credit committee recommendation that the chairman referred to into the record so we can know what we are talking about. >> by unanimous consent so ordered. >> thank you very much. mr. silver, i have had staff hand you a copy of this credit committee recommendation. have you seen this document before? >> no, ma'am. i have not. >> this is the document that the chairman was referring to where the credit committee remanded the project to lgpo, that they denied the application. that's the thing the chairman was referring to and it was also the information that he had up on the screen that was from this memo. now, as i read this document, it says while the project appears to have merit, there are several areas where the information presented did not thoroughly support a finding, but the project is ready to be approved at this time. then it lists four areas that it says need to be supplemented. do you see that? >> yes, ma'am. >> at the bottom

with that, i recognize the ranking member, ms degette, for opening statement. >> two weeks ago, ranking member waxman and i requested testimony from a solyndra president and ceo brian harrison. i am pleased that we have mr. harrison and his colleague, at mr. stover, for today's hearing. i respect that this is have a right to invoke constitutional -- rights -- out -- i respect their witnesses have a right to invoke constitutional rights, but i regret that they will not be answering questions. i hope that once the constitutional questions are resolved, and they will be able to return and testify voluntarily. nonetheless, mr. chairman, i am glad that the subcommittee will continue to examine key questions relating to the solyndra loan guarantee. as i noted in my statement at the september 14 a subcommittee hearing, it is critically important that we understand a number of factors. first, whether the bush and obama administrations conducted due diligence on the loan guarantee, whether solyndra made accurate representations to the government, with the administrations sufficiently monitored t